3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NIH
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
104
Neoplasms
13
Neoplasm Metastasis
8
Sarcoma
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Liposarcoma
4
Multiple Myeloma
3
Head and Neck Neoplasms
3
Glioblastoma
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Breast Diseases
3
Brain Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Inflammation
2
Estrogen Receptor-positive Breast Cancer
2
Esophageal Squamous Cell Carcinoma
2
Interventions
Methotrexate
21
Ifosfamide
21
Cyclophosphamide
19
Doxorubicin
17
Cisplatin
14
Filgrastim
13
Gemcitabine
12
Etoposide
11
Leucovorin
9
apatinib
8
fludarabine
7
glucarpidase
6
Vincristine
6
Temozolomide
6
Radiotherapy
6
Nivolumab
6
Neoadjuvant Therapy
6
Drug Therapy
6
Carboplatin
6
regorafenib
5
cabozantinib
5
Zoledronic Acid
5
Topotecan
5
Mesna
5
Irinotecan
5
Granulocyte Colony-Stimulating Factor
5
Docetaxel
5
pembrolizumab
4
pegfilgrastim
4
camrelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteosarcoma
×
palbociclib
×
Clear all
NCT03242382
2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Unknown
40 enrolled